Focal therapy for prostate cancer – where are we in 2011?

Michael S. Borofsky, Timothy Ito, Andrew B. Rosenkrantz, Samir S. Taneja

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Prostate cancer treatment is a controversial topic amongst physicians and patients alike. Radical therapies such as prostatectomy and whole gland radiation offer the best outcomes in terms of oncologic efficacy, but the decision to undergo treatment must be weighed against its potential morbidity. Over the past decade, the concept of focal therapy for prostate cancer has been introduced as a potential method of achieving oncologic control with a lesser degree of morbidity. Focal therapy refers to isolated ablation of a tumor focus with sparing of uninvolved, surrounding tissue. While it remains in the early stages of development, considerable research is underway that will help determine the optimal method of achieving this goal. Current areas of investigation include appropriate candidate selection, lesion identification, modality of treatment, and follow-up strategies.

Original languageEnglish (US)
Pages (from-to)183-192
Number of pages10
JournalTherapeutic Advances in Urology
Volume3
Issue number4
DOIs
StatePublished - Aug 2011

Bibliographical note

Funding Information:
This work was supported by the Joseph and Diane Steinberg Charitable Trust.

Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.

Keywords

  • cryotherapy
  • focal therapy
  • high-intensity focused ultrasound (HIFU)
  • histoscan
  • prostate cancer

Fingerprint

Dive into the research topics of 'Focal therapy for prostate cancer – where are we in 2011?'. Together they form a unique fingerprint.

Cite this